Completed PHASE3 INTERVENTIONAL 2-arm NCT03016533

Dolutegravir Study in HIV-1 Participants Completing IMPAACT Studies P1093 and P2019

Open-label Access to Dolutegravir for HIV-1 Infected Children and Adolescents Completing IMPAACT Studies P1093 and P2019

Sponsor: ViiV Healthcare

Conditions HIV Infections

Interventions ABC/DTG/3TC film-coated dispersible tablets ABC/DTG/3TC immediate release tablets Dolutegravir film-coated dispersible tablets Dolutegravir film-coated tablets

Updated 24 times since 2017 Last updated: Feb 4, 2026 Started: Jun 6, 2017 Primary completion: Dec 24, 2024 Completion: Dec 24, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates HIV Infections and is currently completed. ViiV Healthcare leads this study, which shows 24 recorded versions since 2017 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

24 versions recorded

Feb 2026 — Present [monthly]

Completed PHASE3
Sep 2025 — Feb 2026 [monthly]

Completed PHASE3
Feb 2025 — Sep 2025 [monthly]

Completed PHASE3

Status: Active Not Recruiting → Completed
Oct 2024 — Feb 2025 [monthly]

Active Not Recruiting PHASE3
Sep 2024 — Oct 2024 [monthly]

Active Not Recruiting PHASE3

▶ Show 19 earlier versions

Jul 2024 — Sep 2024 [monthly]

Active Not Recruiting PHASE3
Mar 2024 — Jul 2024 [monthly]

Active Not Recruiting PHASE3

Status: Recruiting → Active Not Recruiting
Dec 2023 — Mar 2024 [monthly]

Recruiting PHASE3
Nov 2022 — Dec 2023 [monthly]

Recruiting PHASE3
Sep 2022 — Nov 2022 [monthly]

Recruiting PHASE3
Jul 2022 — Sep 2022 [monthly]

Recruiting PHASE3
Feb 2022 — Jul 2022 [monthly]

Recruiting PHASE3
Jan 2022 — Feb 2022 [monthly]

Recruiting PHASE3
Jan 2021 — Jan 2022 [monthly]

Recruiting PHASE3
Oct 2020 — Jan 2021 [monthly]

Recruiting PHASE3
May 2020 — Oct 2020 [monthly]

Recruiting PHASE3
Apr 2020 — May 2020 [monthly]

Recruiting PHASE3
Feb 2020 — Apr 2020 [monthly]

Recruiting PHASE3
Aug 2019 — Feb 2020 [monthly]

Recruiting PHASE3
Nov 2018 — Aug 2019 [monthly]

Recruiting PHASE3
Aug 2018 — Nov 2018 [monthly]

Recruiting PHASE3
Jun 2018 — Aug 2018 [monthly]

Recruiting PHASE3
Aug 2017 — Jun 2018 [monthly]

Recruiting PHASE3

Status: Not Yet Recruiting → Recruiting
Feb 2017 — Aug 2017 [monthly]

Not Yet Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

ViiV Healthcare

Data source: ViiV Healthcare

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Bangkok, Thailand , Belo Horizonte, Brazil , Cape Town, South Africa , Chiang Mai, Thailand , Chiang Rai, Thailand , Fort Lauderdale, United States , Gaborone, Botswana , Harare, Zimbabwe , Johannesburg, South Africa , Los Angeles, United States and 7 more locations